Status:
RECRUITING
Mothers Working to Prevent Early Stillbirth Study 20-28
Lead Sponsor:
University of Manchester
Collaborating Sponsors:
University of Birmingham
University of Leicester
Conditions:
Stillbirth and Fetal Death
Perinatal Death
Eligibility:
FEMALE
16-50 years
Brief Summary
This project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision. The death ...
Detailed Description
Research question What are the modifiable risk factors for early stillbirth (between 20-28 weeks' gestation)? Background The NHS Long Term Plan sets a goal to reduce stillbirth by 50% by 2025 (from 2...
Eligibility Criteria
Inclusion
- Cases
- Bereaved mothers/parents who have recently birthed a singleton baby who died before/during or immediately after labour between 20 and 28 weeks of pregnancy.
- Baby has no evidence of congenital anomaly
- Able to give written informed consent
- Controls
- Pregnant women/people with an ongoing pregnancy (at the target gestation) receiving antenatal care from a participating maternity unit, at a gestation matched to the distribution of stillbirths between 20 to 28 weeks of pregnancy in the same unit
- Baby has no evidence of congenital anomaly
- Able to give written informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
948 Patients enrolled
Trial Details
Trial ID
NCT06005272
Start Date
September 1 2023
End Date
March 31 2027
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom, M13 9WL